Diagnosis involves the combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Individualised treatment plans for treatment and management of non-complete IVs, usually including drug therapy, rehabilitation, regular follow-up, and other multidimensional management, are needed.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, with timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of type IV osteoporosis.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.